TP53 and neoplasm: To further improve the accuracy of the prognostic, we constructed a nomogram that integrated immunoscore and clinical information, including TP53 status, tumor stage, tumor location, and microsatellite status to quantitatively predict the prognosis of CRC patients in the GEO cohort.